SCHEMBL7969084

SCHEMBL7969084

CNC1c2ccccc2CC1N(C)C

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 12/20 0.41
HTR2C P28335 12/20 0.41
HTR2B P41595 12/20 0.41
HRH3 Q9Y5N1 12/20 0.41
SIGMAR1 Q99720 5/20 0.41
PDPK1 O15530 1/20 0.41
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9772643 1.00 HTR2A (0.41) HTR2AHTR2CHTR2BHRH3SIGMAR1
SCHEMBL27203859 0.79 MAPK1 (0.46) HTR2AHTR2CHTR2BHRH3SIGMAR1
SCHEMBL14076218 0.76 DRD2 (0.50) HTR2AHTR2CHTR2BHRH3SIGMAR1
SCHEMBL2578214 0.76 SIGMAR1 (0.45) HTR2AHTR2CHTR2BSIGMAR1PDPK1
SCHEMBL12422089 0.76 MAOB (0.46) HTR2AHTR2CHTR2BSIGMAR1PDPK1
SCHEMBL15304297 0.76 MAOB (0.46) HTR2AHTR2CHTR2BSIGMAR1PDPK1
SCHEMBL12422094 0.76 MAOB (0.46) HTR2AHTR2CHTR2BSIGMAR1PDPK1
SCHEMBL12422090 0.76 MAOB (0.46) HTR2AHTR2CHTR2BSIGMAR1PDPK1
SCHEMBL15705297 0.76 SIGMAR1 (0.45) HTR2AHTR2CHTR2BSIGMAR1PDPK1
SCHEMBL2578228 0.76 SIGMAR1 (0.45) HTR2AHTR2CHTR2BSIGMAR1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271395-B1 E.G.,(.+-.)-N-(2,3-DIHYDRO-2-(1-PYRROLIDINYL)-1H-INDEN-1-Y1) -2 ,4-DINITRO-N-METHYL-BENZENE-ACETAMIDE; STRONG AFFINITY FOR OPTICAL RECEPTORS, CENTRAL ANALGESIC, DIURETIC, ANTIARRYTHMIC, HYPOTENSIVE AND ANTIISCHEMIC ACTIVITY. HOECHST MARION ROUSSOL (FR) 2001-08-07 US disclosed
EP-0258096-B1 INDANE DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE INTERMEDIATES OBTAINED ROUSSEL-UCLAF (FR) 1992-09-09 EP disclosed